145 related articles for article (PubMed ID: 37075976)
1. Alzheimer's disease-associated mutant ubiquitin (UBB
Wagh AR; Sulakshane P; Glickman MH
Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194936. PubMed ID: 37075976
[TBL] [Abstract][Full Text] [Related]
2. Disease-associated mutant ubiquitin causes proteasomal impairment and enhances the toxicity of protein aggregates.
Tank EM; True HL
PLoS Genet; 2009 Feb; 5(2):e1000382. PubMed ID: 19214209
[TBL] [Abstract][Full Text] [Related]
3. Role of frameshift ubiquitin B protein in Alzheimer's disease.
Chen X; Petranovic D
Wiley Interdiscip Rev Syst Biol Med; 2016 Jul; 8(4):300-13. PubMed ID: 27240056
[TBL] [Abstract][Full Text] [Related]
4. Long-term proteasomal inhibition in transgenic mice by UBB(+1) expression results in dysfunction of central respiration control reminiscent of brainstem neuropathology in Alzheimer patients.
Irmler M; Gentier RJ; Dennissen FJ; Schulz H; Bolle I; Hölter SM; Kallnik M; Cheng JJ; Klingenspor M; Rozman J; Ehrhardt N; Hermes DJ; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Meyer HE; Hopkins DA; Van Leeuwen FW; Beckers J
Acta Neuropathol; 2012 Aug; 124(2):187-97. PubMed ID: 22730000
[TBL] [Abstract][Full Text] [Related]
5. Review: unchained maladie - a reassessment of the role of Ubb(+1) -capped polyubiquitin chains in Alzheimer's disease.
Chadwick L; Gentle L; Strachan J; Layfield R
Neuropathol Appl Neurobiol; 2012 Apr; 38(2):118-31. PubMed ID: 22082077
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease.
van Tijn P; de Vrij FM; Schuurman KG; Dantuma NP; Fischer DF; van Leeuwen FW; Hol EM
J Cell Sci; 2007 May; 120(Pt 9):1615-23. PubMed ID: 17405812
[TBL] [Abstract][Full Text] [Related]
7. Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death.
De Vrij FM; Sluijs JA; Gregori L; Fischer DF; Hermens WT; Goldgaber D; Verhaagen J; Van Leeuwen FW; Hol EM
FASEB J; 2001 Dec; 15(14):2680-8. PubMed ID: 11726544
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical effects of mutant ubiquitin on Aβ plaque formation in an Alzheimer mouse model.
Verheijen BM; Stevens JAA; Gentier RJG; van 't Hekke CD; van den Hove DLA; Hermes DJHP; Steinbusch HWM; Ruijter JM; Grimm MOW; Haupenthal VJ; Annaert W; Hartmann T; van Leeuwen FW
Neurobiol Aging; 2018 Dec; 72():62-71. PubMed ID: 30216939
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression.
Hope AD; de Silva R; Fischer DF; Hol EM; van Leeuwen FW; Lees AJ
J Neurochem; 2003 Jul; 86(2):394-404. PubMed ID: 12871580
[TBL] [Abstract][Full Text] [Related]
10. Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease.
van Tijn P; Dennissen FJ; Gentier RJ; Hobo B; Hermes D; Steinbusch HW; Van Leeuwen FW; Fischer DF
Neurochem Int; 2012 Oct; 61(5):739-48. PubMed ID: 22797007
[TBL] [Abstract][Full Text] [Related]
11. Low levels of mutant ubiquitin are degraded by the proteasome in vivo.
van Tijn P; Verhage MC; Hobo B; van Leeuwen FW; Fischer DF
J Neurosci Res; 2010 Aug; 88(11):2325-37. PubMed ID: 20336771
[TBL] [Abstract][Full Text] [Related]
12. Mutant ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in association with neuronal degeneration.
Tan Z; Sun X; Hou FS; Oh HW; Hilgenberg LG; Hol EM; van Leeuwen FW; Smith MA; O'Dowd DK; Schreiber SS
Cell Death Differ; 2007 Oct; 14(10):1721-32. PubMed ID: 17571083
[TBL] [Abstract][Full Text] [Related]
13. Frameshift proteins in Alzheimer's disease and in other conformational disorders: time for the ubiquitin-proteasome system.
van Leeuwen FW; Hol EM; Fischer DF
J Alzheimers Dis; 2006; 9(3 Suppl):319-25. PubMed ID: 16914870
[TBL] [Abstract][Full Text] [Related]
14. UBB
Chen X; Muñoz-Arellano AJ; Petranovic D
Aging (Albany NY); 2021 Nov; 13(21):23953-23980. PubMed ID: 34751669
[TBL] [Abstract][Full Text] [Related]
15. Long-term proteasome dysfunction in the mouse brain by expression of aberrant ubiquitin.
Fischer DF; van Dijk R; van Tijn P; Hobo B; Verhage MC; van der Schors RC; Li KW; van Minnen J; Hol EM; van Leeuwen FW
Neurobiol Aging; 2009 Jun; 30(6):847-63. PubMed ID: 18760506
[TBL] [Abstract][Full Text] [Related]
16. Characterizing polyubiquitinated forms of the neurodegenerative ubiquitin mutant UBB
Chojnacki M; Zhang D; Talarowska M; Gałecki P; Szemraj J; Fushman D; Nakasone MA
FEBS Lett; 2016 Dec; 590(24):4573-4585. PubMed ID: 27861798
[TBL] [Abstract][Full Text] [Related]
17. The Molecular Misreading of APP and UBB Induces a Humoral Immune Response in Alzheimer's Disease Patients with Diagnostic Ability.
Montero-Calle A; San Segundo-Acosta P; Garranzo-Asensio M; Rábano A; Barderas R
Mol Neurobiol; 2020 Feb; 57(2):1009-1020. PubMed ID: 31654319
[TBL] [Abstract][Full Text] [Related]
18. The mechanism of cytokeratin aggresome formation: the role of mutant ubiquitin (UBB+1).
Bardag-Gorce F; Riley N; Nguyen V; Montgomery RO; French BA; Li J; van Leeuwen FW; Lungo W; McPhaul LW; French SW
Exp Mol Pathol; 2003 Apr; 74(2):160-7. PubMed ID: 12710947
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease-associated ubiquitin mutant Ubb
Munari F; Bortot A; Assfalg M; D'Onofrio M
Int J Biol Macromol; 2018 Mar; 108():24-31. PubMed ID: 29175520
[TBL] [Abstract][Full Text] [Related]
20. Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain.
Fischer DF; De Vos RA; Van Dijk R; De Vrij FM; Proper EA; Sonnemans MA; Verhage MC; Sluijs JA; Hobo B; Zouambia M; Steur EN; Kamphorst W; Hol EM; Van Leeuwen FW
FASEB J; 2003 Nov; 17(14):2014-24. PubMed ID: 14597671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
